Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma
Conditions: Progression-free Survival; Overall Survival; Toxicity Interventions: Drug: pegylated liposomal doxorubicin; Drug: pirarubicin Sponsors: Peking University People's Hospital; Peking University Shougang Hospital; Chinese PLA General Hospital; Beijing Jishuitan Hospital; Xijing Hospital; Peking Union Medical College Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials